In re Watson Fentanyl Patch Products Liability Litigation
United States Judicial Panel on Multidistrict Litigation
1Opinion of the Court
TRANSFER ORDER
JOHN G. HEYBURN II, Chairman.
Before the Panel: Pursuant to 28 U.S.C. § 1407, plaintiffs in 22 actions that involve injuries arising from the use of allegedly defective Watson fentanyl patches move to centralize this litigation in the Northern District of Illinois. This litigation currently consists of 22 actions pending in fifteen districts, as listed on Schedule A.1
Watson defendants2 support centralization of all fentanyl patch litigation, not just *1351the actions against Watson. Watson suggests that we select one of three districts in which no action is pending — the Northern…
2Cases cited2 opinions
- In re Yellow Brass Plumbing Component Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2012
- In Re ClassicStar Mare Lease LitigationUnited States Judicial Panel on Multidistrict Litigation · 2007
3Cited by37 opinions
- In re Invokana (CANAGLIFLOZIN) Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2016
- In re Zostavax (Zoster Vaccine Live) Prods. Liab. Litig.United States Judicial Panel on Multidistrict Litigation · 2018
- Bokhari v. Torrent Pharmaceuticals LimitedDistrict Court, N.D. California · 2020
- Bon Secours Mercy Health, Inc. v. Blue Cross Blue Shield AssociationDistrict Court, N.D. Alabama · 2025
- Bon Secours Mercy Health, Inc. v. Blue Cross Blue Shield AssociationDistrict Court, N.D. California · 2025
32 more not listed; retrieve them via the Exa API.